Skip to main content
O

Oncobix

Oncobix provides a cloud‑based analytics platform that aggregates multi‑omics cancer data and uses machine‑learning to automatically annotate variants, rank evidence, and generate concise clinical reports. The solution offers interactive dashboards, EHR/LIMS integration via FHIR APIs, and real‑time alerts to help oncologists and molecular tumor boards make faster, evidence‑based treatment decisions while maintaining HIPAA‑compliant security.

용인시, South KoreaFounded 20161210+ followers
Updated 2 months ago

Funding

$2.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Healthcare providers lack an integrated, AI-driven platform to efficiently analyze and interpret complex oncology genomic data, leading to slower treatment decisions and suboptimal patient outcomes.

Solution

Oncobix offers a cloud-based analytics suite that aggregates multi-omics data, applies machine-learning models to identify actionable mutations, and generates concise clinical reports. The platform automates data preprocessing, variant annotation, and evidence ranking, reducing manual bioinformatics effort. Clinicians can access interactive dashboards that visualize tumor profiles, compare against clinical trial eligibility, and receive treatment recommendations aligned with current guidelines. Secure data exchange APIs enable seamless integration with electronic health records and laboratory information systems, ensuring compliance with privacy regulations. Continuous model updates incorporate the latest research findings, keeping recommendations current.

Target Audience

Primary users are oncologists, molecular tumor boards, and precision medicine programs within hospitals and cancer research centers.

Features

  • Automated ingestion and normalization of genomic, transcriptomic, and proteomic datasets
  • AI-powered variant interpretation engine with evidence-based scoring
  • Interactive visual dashboards for tumor mutational burden, pathway analysis, and drug matching
  • Integration APIs for EHR, LIMS, and clinical trial registries (FHIR compatible)
  • Role-based access control and end-to-end encryption for HIPAA compliance
  • Real-time alerts for newly approved therapies or relevant clinical trials
This profile is AI-generated and may contain inaccuracies.